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Objective: Transcanal exclusive endoscopic ear surgery requires the management of 
the endoscope and the surgical instruments in the external auditory canal. Bleeding 
in this narrow space is one of the most challenging issues, especially for novice 
endoscopic ear surgeons. We aim to assess the severity and occurrence of bleeding 
and describe strategies to control the bleeding during endoscopic ear surgery. We 
hypothesize that bleeding is reasonably controllable in endoscopic ear surgery.  
Study Design: Case series with chart review. 
Setting: Tertiary referral center. 
Subjects and Methods: We retrospectively assessed 104 consecutive cases of 
exclusive endoscopic ear surgery at the University Hospital of Modena, Italy. The 
surgical videos and the patient charts were carefully investigated and analyzed. 
Results: Used hemostatic agents were: injection of diluted epinephrine 1:200’000 
(2% with mepivacaine), cottonoids soaked with epinephrine (1:1000), monopolar or 
bipolar cautery, washing with H2O2 and self-suctioning instruments. The localization 
of bleeding in the external auditory canal was most frequently the posterior superior 
part and inside of the middle ear it was the pathology itself. The statistical analysis 
revealed significant differences comparing the mean arterial pressure and the type of 
intervention between different bleeding scores.  
Conclusion: The management of bleeding in endoscopic ear surgery is feasible using 
widely available hemostatic agents in reasonable frequency. This study gives an 
instructive overview on how to manage the bleeding in the exclusive endoscopic 
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The exclusive endoscopic transcanal approach to the middle ear is nowadays 
gaining popularity for various indications1. In almost every field of otologic surgery, 
even in pediatric patients2 or approaches to the lateral skull base3, the endoscope 
has become a valuable tool. The main advantage of the endoscope is the enhanced 
visibility of the anatomy and pathology, due to the wide-angled views and the 
possibility to use angled scopes to explore hidden recesses such as the retro- and 
hypotympanum4. However, the one-handed surgical technique is challenging for the 
surgeon and bleeding in the external auditory canal (EAC) and the middle ear is a 
major concern. Due to the limited space in the EAC and the middle ear, a clean 
surgical field is mandatory to ensure patient safety and to benefit from the wide-angle 
vision offered by the endoscope. Moreover, even slight bleeding threatens the 
surgical field since the lens of the scope inside the EAC gets smeared. Since the 
aspiration of blood and debris requires the removal of the instrument from the EAC 
and the introduction of a suction tube, the management of bleeding is important to 
ensure the progress of the operation. The knowledge of the different considerations 
and procedures to ensure hemostasis is especially for novices in exclusively 
endoscopic ear surgery (EES) very important. The control of bleeding during the 
initial steps of the operation is the key to a successful take off in this emerging 
technique5.  
However, a scientific analysis and an instructive description of the management of 
bleeding in EES is still lacking in literature. We aim to give an overview on the 
occurrence and the severity of bleeding during EES and to identify possible 
predicting factors for a more severe intraoperative bleeding. Furthermore, we aim to 




successfully and safely accomplish the planned intervention. We hypothesize that 
bleeding is well controllable during EES. 
 
Patients and Methods 
We assessed 104 consecutive cases of exclusive endoscopic ear surgery performed 
at the University Hospital of Modena from November 2015 to March 2017. Surgical 
video recordings from our database were analyzed along with a retrospective clinical 
chart analysis. General data of the patients, personal medication and details of the 
continuously recorded anesthesiology protocols were assessed and tabularized. For 
this kind of retrospective investigation the local ethical committee of the University 
Hospital of Modena does not perform a formal ethical assessment. The study was 
performed according to the declaration of Helsinki. Statistical analysis was performed 
using GraphPad Prism. 
The assessment of bleeding severity was performed according to the Boezaart 
grading scale6, which was initially designed for sinus surgery, but has recently found 
its use in otologic surgery as well7. This scale ranging from 0 to 5 is defined as 
follows: 0: no bleeding; 1: slight bleeding requiring no suction; 2: slight bleeding 
requiring occasional suctioning without threatening the surgical field; 3: slight 
bleeding requiring frequent suctioning, bleeding threatens surgical field a few 
seconds after removal of the aspiration; 4: moderate bleeding requiring frequent 
suctioning, bleeding threatens surgical field immediately after suction is removed; 5: 
severe bleeding: constant suctioning required, surgical field severely threatened. For 
every case two investigators assessed a bleeding score for the EAC and the middle 
ear. Additionally, we recorded the exact localization of the bleeding in the EAC and 




The different methods used to achieve hemostasis during exclusive endoscopic ear 
surgery were identified to be the following: injection of diluted epinephrine 1:200’000 
(2% with mepivacaine) into the EAC skin, bipolar or monopolar cautery (BOWA ARC 
350 monopolar CUT maximal output power 300 W used at 10% of maximal power 
settings with a needle tip),  epinephrine (1:1000) soaked cottonoids, washing with 
hydrogen peroxide (H2O2), use of a third hand and the use of self-suctioning 
instruments (Panetti instruments). 
 
Results 
We assessed a total of 104 surgical interventions. The surgical procedures were 
distributed as follows: tympanoplasty (+/- ossiculoplasty) for cholesteatoma (53%), 
stapedotomy (25%), type 1 tympanoplasty (13%), endoscopic approaches to the 
internal auditory canal (6%) and removal of middle ear tumors (3%). Twenty-three 
percent were cases of revision surgery and 15% were pediatric cases with age less 
than 16 years at the date of the operation. The main characteristics of the patients 
including bleeding severity and anesthesiological data are summarized in Table 1.  
The required hemostatic agents were analyzed according to the bleeding scale and 
divided into EAC and middle ear evaluation and the results summarized in Figure 1. 
The mean injection of diluted epinephrine 1:200’000 (2% with mepivacaine) into the 
EAC was 1.2 mL and mean 3.7 cottonoids soaked with epinephrine (1:1000) were 
necessary to control the bleeding. The use of monopolar cautery to elevate the 
tympano-meatal flap (TMF) was observed in 79% whereas the use of monopolar or 
bipolar cautery for hemostasis was necessary only in 12% and 13% respectively. The 
use of these basic hemostatic agents is illustrated in Figure 2. Inside the middle ear 
three epinephrine soaked cottonoids and one cottonoid without epinephrine were on 




hemostasis were used in 9% and 8% respectively. We observed two cases of 
extended glomus tympanicus type A, which were rated with the highest values on the 
bleeding scale. To allow constant suctioning of blood a second surgeon introduced 
an aspirator into the middle ear. Other used hemostatic agents were washing with 
H2O2 and self-suctioning instruments.  
The localization of bleeding in the EAC was most frequently the posterior superior 
part (40.4%) followed by posterior inferior (20.2%), inferior (4.8%), anterior (2.9%) 
and multiple locations (26.9%). No specific bleeding location was observed in 4.8%. 
Inside the middle ear the most abundant source of bleeding was the pathology itself 
with 25.9% as well as granulation or scar tissue (8.7%). The most common 
anatomical source of hemorrhage was the anterior malleolar ligament (20.2%) and 
less frequent: the posterior malleolar ligament (1.9%). Multiple sources were 
observed in 16.4%. No bleeding was observed in 26.9% of the cases. 
The continuously recorded mean arterial pressure (MAP) and the heart rate (HR) 
were analyzed according to the bleeding scale as shown in Figure 3. Due to age-
related differences, the pediatric cohort has been excluded from this analysis. The 
statistical analysis revealed significant differences between the bleeding scale groups 
for the MAP in both EAC and middle ear validation. The HR differed statistically 
significant only in one comparison (EAC between bleeding scale 1 and 3). All other 
comparisons regarding the HR were statistically not significant. 
The type of intervention was an important factor leading to statistically significant 
increased severity of bleeding in the middle ear. The comorbidities according to the 






This study assesses the occurrence and severity of bleeding during transcanal EES 
for various indications, as well as its management. Intraoperative bleeding has been 
considered a major concern of EES, especially when compared to microscopic 
approaches to the middle ear, where the two-handed technique allows constant 
suctioning of blood. Due to the one handed surgical technique, the management of 
bleeding is crucial to maintain the surgical field clean and not to impede with the 
progress of the operation. The development of optimal strategies is particularly 
important for beginners in EES, since the management of a possibly narrow and 
bleeding EAC may be frustrating5. In our experience the initial steps during elevation 
of the TMF are challenging to a novice surgeon and require patience to repeatedly 
clean the surgical field in order to safely perform the required surgical steps. 
According to our results we suggest the injection of diluted epinephrine 1:200’000 
(2% with mepivacaine) into the posterior superior part of the EAC skin. As assessed 
in this study the most common localization of bleeding is in the posterior and superior 
portion of the EAC, where the main vascular supply runs. Indeed, the bony portion is 
vascularized by the internal maxillary artery through its anterior tympanic and deep 
auricular branches, the superficial temporal artery and the posterior auricular artery8. 
Figure 4 illustrates the EAC and middle ear vascularization in a schematic drawing. 
From an anatomical point of view a retroauricular infiltration could be beneficial to 
achieve not only a peripheral vasoconstriction inside the EAC but rather an effect on 
the main trunk of the posterior auricular artery. The same consideration applies for a 
pre-tragal infiltration for the superficial temporal artery and its anterior auricular 
branches. However, this question would require proper investigation. 
The elevation of the TMF starts thereafter using a monopolar cautery at lowest 
intensity. This is an important safety issue, as a theoretic risk from current spread for 




coagulation, we did not observe any facial palsy in our cohort. Moreover, the skin is 
cauterized in a selective (point-shaped) manner in order to prevent retraction of the 
flap as shown in Figure 2. The incision is thereafter completed with cold instruments. 
Epinephrine soaked neuro-patties are used to pack sources of bleeding in order to 
achieve a clean surgical field. In average 3.7 neuro-patties were required per case to 
perform the elevation of the TMF. This is a very low number and therefore we can 
consider the effort to achieve a clean surgical field reasonable. Moreover, the 
injection of diluted epinephrine (1:200’000) and topical application of epinephrine 
(1:1000) can be considered safe, as previously investigated in functional endoscopic 
sinus surgery (FESS)9,10. Persistent residual sources of bleeding are treated as 
required with monopolar or bipolar electro cautery. However it is crucial to use the 
cautery sparingly in order to avoid retraction of the TMF.  
Inside the middle ear cleft, the bleeding is largely depending on the pathology 
encountered. Especially cholesteatomas with abundant granulation tissue or scar 
tissue in revision surgery are common sources of bleeding. The most severe 
bleeding however was observed during removal of highly vascularized glomus 
tympanicus type A tumors. As the middle ear bears more risk for iatrogenic damage 
the hemostatic agents were used even more conservative way. The careful 
application of cottonoids, patience and repeated cleaning of the surgical field is 
mandatory to safely perform the intervention. However, in cases of a dehiscent facial 
nerve we do not use epinephrine inside the middle ear. The rationale is not to impede 
with the neuronal micro-vascularization.  
We wish to emphasize, that we did not observe any shift to the microscopic 
technique due to bleeding in the whole cohort. This fact itself represents a substantial 
argument to the critical voices concerning the management of bleeding in EES. Even 




However, we have to consider that difficult cases were operated by experienced 
surgeons with at least 10 years of experience in EES and extensive prior experience 
in microscopic ear surgery. Therefore, we clearly conclude that novice surgeons to 
EES should not perform revision surgery, cases of extended cholesteatomas or 
middle ear tumor removal to take off with this technique. In our opinion it is important 
to start with simple tasks such as myringotomy and ventilation tube insertion or type 
1 tympanoplasty.  
Limitations of the present study are its retrospective design and the Boezaart 
bleeding scale, which was not primary developed for ear surgery and has been used 
only once before. Moreover, this subjective grading may be subject to a significant 
interobserver variability regarding the bleeding score. This issue could be addressed 
in the present study due to the use of recorded surgical videos for data collection. For 
cases with unclear bleeding score, the investigators were able to review the 
procedure several times in order to decide by consent, which grading would be most 
appropriate. 
According to our results (Figure 4) the anesthesiologist plays a crucial role to the 
success of EES. We observed an association of higher bleeding scores to higher 
MAP. Adequate hemostasis depends on the anesthesiological management and 
appropriate preventive measures11. However, controlled hypotension is not without 
risk: in addition to the adverse effects of certain pharmacologic agents, it may cause 
tissue hypoxia by reducing microcirculatory autoregulation of vital organs. Therefore, 
the anesthesiologist has to balance the MAP in order to safely perform a controlled 
hypotension12. The anesthesiological management starts with appropriate pre-
medication. In our experience the first choice in case of decompensated 
hypertension is intravenous clonidine 75-150 μg, while the second choice is labetalol 




pressure. According to Ramchandani et al. intravenous clonidine premedication is 
effective to obtain a clean surgical field also in patients undergoing middle ear or 
nasal surgery, even if presenting a normal blood pressure13. 
A controlled intraoperative hypotension plays a key role since the patient’s baseline 
mean arterial pressure may be reduced by 30% or kept at 60-70 mmHg. 
Anesthesiological strategies for blood pressure control consist in either total 
intravenous anesthesia (TIVA) with propofol and remifentanil or inhalational 
anesthesia (IA) with propofol induction followed by sevoflurane 1-2% in association 
with remifentanil. Another important factor is the management of reflex tachycardia 
occurring with decreased MAP. Sevoflurane for instants causes a peripheral venous 
dilation and it is likely to produce a mild tachycardia as a compensatory reflex. 
Despite a reduced MAP, the surgical field may not improve significantly, owing to 
reflex tachycardia maintaining cardiac output high. To address this phenomenon the 
administration of centrally acting presynaptic alpha-2 agonists (clonidine, 
dexmedetomidine), beta-blockers (esmolol) or magnesium sulfate have been 
proposed7,11. Ryu et al. found that magnesium sulphate and remifentanil in 
combination with sevoflurane provided adequate controlled hypotension and proper 
surgical conditions for middle ear surgery. Moreover, patients receiving magnesium 
sulphate had a favorable postoperative course14. Our experience with standard IA is 
excellent. Although some authors prefer a TIVA, there are no significant differences 
in rate of blood loss (in milliliters per hour) or subjective measure of endoscopic 
visualization at least in FESS15,16. Of course no conclusions may be drawn regarding 
this subject without a decent comparative study for EES.  
In our experience muscle relaxation does not seem to have any influence on the 
bleeding and is never applied in EES as it interferes with facial nerve monitoring. The 




pressure (PEEP) creates a Valsalva effect and in consequence higher bleeding 
scores and is therefore avoided wherever possible. Another important consideration 
is not to exaggerate the intraoperative administration of fluids. 
 
Conclusion 
The management of bleeding in EES is feasible using widely available hemostatic 
agents in reasonable frequency. This study gives an instructive overview on how to 
manage the bleeding in EES. Risk factors for more important bleeding include the 
type of middle ear pathology and a high MAP. Even highest bleeding scores could be 
managed in an exclusively endoscopic technique, no shift to the microscopic 
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Table 1: Distribution of patient’s characteristics. SD: standard deviation, MAP: mean 
arterial pressure, HR: heart rate, BMI: body mass index, ASA: American society of 
anesthesiologists, IA: inhalational anesthesia  






Mean Age (range) 42 (3-83) 48 (16-83) 10 (3-15) 
Female sex 60 (58%) 55 (63%) 5 (31) 
Left side 56 (54%) 43 (49%) 13 (81) 
 
Type of surgery 
   
Type 1 tympanoplasty 14 12 2 
Tympanoplasty for cholesteatoma 55 41 14 
Stapedotomy 26 26 0 
Endoscopic lateral skull base surgery 6 6 0 
Middle ear tumor removal 3 3 0 
Revision surgery 24 (23%) 17 (19%) 7 (44%) 
 
Bleeding scores and vital signs 
   
Mean EAC bleeding score (+/-SD) 2.17 (+/- 0.82) 2.13 (+/- 0.83) 2.44 (+/- 0.73) 
Mean EAC MAP (+/-SD) 70.6 (+/- 12.9) 70.9 (+/- 13.3) 68.8 (+/- 10.5) 
Mean EAC HR (+/-SD) 66.8 (+/- 15.3) 63.0 (+/- 9.6) 87.9 (+/- 22.7) 
Mean middle ear bleeding score (+/-SD) 2.00 (+/- 1.16) 1.85 (+/- 1.12) 2.81 (+/- 1.05) 
Mean middle ear MAP (+/-SD) 68.3 (+/- 12.2) 68.2 (+/- 12.6) 68.9 (+/- 9.6) 
Mean middle ear HR (+/-SD) 64.2 (+/- 14.5) 60.3 (+/- 8.5) 86.0 (+/- 20.7) 
 
Relevant comorbidities 
   
Hypertension 16 16 0 
Diabetes mellitus 5 5 0 
Heart/Vessel disease 7 6 1 
Lung disease 3 3 0 
Thyroid disease 7 7 0 
Coagulation abnormalities 1 1 0 
BMI > 30 kg/m2 7 7 0 
Acetylsalicylic acid 4 4 0 
Anticoagulant 2 2 0 
 
ASA class 
   
I 61 49 12 
II 36 32 4 
III 6 6 0 
IV 1 1 0 
 
Type of anesthesia 
   
IA (Sevoflurane/Remifentanyl) 82 67 15 
IA (Desflurane/Remifentanyl) 19 18 1 




Table 2: Statistical comparison of bleeding scores according to the type of 
intervention and the ASA class. Note the high bleeding scores during middle ear 
tumor removal (glomus tympanicus). EAC: external auditory canal, ME: middle ear, 
ASA: American Society of Anesthesiologists 
 
 Mean bleeding scores 
(95% CI) 
 
EAC              Middle ear 
p-value 
Type of intervention   0.196 < 0.0001 
Stapedotomy 1.83 
(1.41 - 2.26) 
0.94 
(0.63 - 1.26) 
  
Type 1 tympanoplasty 2.50 
(1.73 - 3.27) 
2.00 





(1.97 - 2.40) 
2.35 
(2.02 - 2.68) 
  
Middle ear tumor removal 1.67 
(0.23 - 3.10) 
4.33 
(1.47 - 7.20) 
  
Lateral skull base surgery 2.17 
(1.14 - 3.20) 
1.50 
(0.05 - 2.95) 
  
Revision surgery 2.33 
(1.99 - 2.68) 
2.00 
(1.59 - 2.41) 
  
Comorbidities   0.288 0.651 
ASA I 2.12 
(1.92 - 2.31) 
1.89 
(1.59 - 2.19) 
  
ASA II 2.22 
(1.92 - 2.53) 
2.14 
(1.74 - 2.54) 
  
ASA III/IV 2.43 
(1.70 - 3.16) 
2.29 









Figure 1: The used hemostatic agents are illustrated according to the bleeding 
scores. Panel A and B represent data for the external auditory canal, where as Panel 
C and D represent data for the middle ear evaluation. 
 
Figure 2: Hemostatic agents used in the external auditory canal. A: Injection of 




meatal flap; C: cottonoid pledges soaked with epinephrine; D: bipolar cautery to 
control residual bleeding. 
 
Figure 3: Mean arterial pressure (MAP) and heart rate (HR) are illustrated for the 
external auditory canal (A) and the middle ear (B). The statistical analysis reveals 
significant differences between group allocations for the MAP. 
 
Figure 4: Schematic illustration of the vascular supply for the external auditory canal 
(A) and the middle ear cleft (B). paa: posterior auricular artery, sma: stylomastoid 
artery, tsa: temporal superficial artery with aab: anterior auricular branches, ma: 
maxillary artery, daa: deep auricular artery, eca: external carotid artery, ata: anterior 
tympanic artery, pta: posterior tympanic artery, ita: inferior tympanic artery, sta: 




with ctb: carotid tympanic branches, mma: middle meningeal artery, jvb: jugular vein 
bulb 
